We now show that activation of ERK1/2 during MI specifically occurs in myeloid cells infiltrating the ischemic heart and that intervention with the MEK inhibitor trametinib significantly diminishes the CCR2-dependent (40) Ly6Chi monocyte recruitment into the infarcted myocardium. Here, MAPK3 is linked to myocardial infarction.